Schedule 13D ownership disclosure
Arcus Biosciences Inc
Security class unavailable · CUSIP: 03969F109
Event date: 2018-03-19
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,292,740
- Percent of class
- 9.3400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001564590-20-008994
- Form type
- SC 13D
- Filer
- Arcus Biosciences, Inc.
- CIK
- CIK 1724521
- Filed
- Mar 05, 2020
- Reporting period
- Mar 19, 2018
- Description
- Schedule 13D beneficial ownership